Literature DB >> 34486416

The Role of Human-Centered Design in Insulin Pen Innovation and the Future of Insulin Delivery.

Jessica L Watterson1, Auriel August2,3, Jesse Fourt2, Talya Brettler2.   

Abstract

Insulin pens have made a dramatic impact on diabetes care, with evidence suggesting that they promote performance of self-care and reduce negative health outcomes for people with diabetes. Human-centered design (HCD), practiced by IDEO for over 40 years and together with Eli Lilly for over 15 years, has helped to design insulin pens that evolved with the needs of people with diabetes. HCD employs unique methods that help to uncover people's needs and design with them in mind. The future of diabetes care is bright with the ongoing application of HCD methodology in this space.

Entities:  

Keywords:  design research; design thinking; diabetes; human-centered design; insulin pens

Mesh：

Substances：

Year:  2021        PMID： 34486416      PMCID： PMC9294580          DOI： 10.1177/19322968211043921

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


  11 in total

1.  Smart Pens Will Improve Insulin Therapy.

Authors:  David C Klonoff; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2018-02-07

2.  Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes.

Authors:  A N Lteif; W F Schwenk
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

3.  Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Authors:  Won Chan Lee; Sanjeev Balu; David Cobden; Ashish V Joshi; Chris L Pashos
Journal:  Clin Ther       Date:  2006-10       Impact factor: 3.393

Review 4.  Evolution of diabetes insulin delivery devices.

Authors:  Jean-Louis Selam
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.

Authors:  David Cobden; Won Chan Lee; Sanjeev Balu; Ashish V Joshi; Chris L Pashos
Journal:  Pharmacotherapy       Date:  2007-07       Impact factor: 4.705

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.

Authors:  Mary Korytkowski; David Bell; Carol Jacobsen; Rudee Suwannasari
Journal:  Clin Ther       Date:  2003-11       Impact factor: 3.393

Review 9.  Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas.

Authors:  Jothydev Kesavadev; Banshi Saboo; Meera B Krishna; Gopika Krishnan
Journal:  Diabetes Ther       Date:  2020-05-14       Impact factor: 2.945

10.  Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology.

Authors:  Nikhil A Sangave; Timothy D Aungst; Dhiren K Patel
Journal:  Diabetes Spectr       Date:  2019-11
View more
  2 in total

1.  Nonmedical Transdisciplinary Perspectives of Black and Racially and Ethnically Diverse Individuals About Antiracism Practices: A Qualitative Study.

Authors:  Megha Shankar; Joy Cox; Juliana Baratta; Gisselle De Leon; Jonathan G Shaw; Sonoo Thadaney Israni; Donna M Zulman; Cati G Brown-Johnson
Journal:  JAMA Netw Open       Date:  2022-02-01

2.  Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary.

Authors:  Thomas Sparre; Niels-Aage B Hansen; Anya Sonia Wernersson; Mark Guarraia
Journal:  J Diabetes Sci Technol       Date:  2021-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.